source
- Vertex to acquire Crinetics in $10 billion deal, adding rare-disease drug Palsonify to its portfolioVertex Pharmaceuticals announced a $10 billion transaction to purchase Crinetics Pharmaceuticals. The deal will bring Crinetics' recently launched drug Palsonify into Vertex's portfolio. Palsonify…
- STAT newsletter highlights the decline of employer-based health insurance in the U.S.John Wilkerson, a Washington correspondent for STAT, writes the D.C. Diagnosis newsletter that focuses on health policy. In this edition he turns his attention to the weakening of the employer-base…